Figure 4. Overall survival based on tissue factor-bearing microparticle status.
Median survival for study subjects with higher concentration of tissue factor-bearing microparticles (TFMP) on observation (blue) was 11.8 months compared with 17.8 months on enoxaparin (green, Log-rank test P-value=0.58). The median survival for lower tissue factor-bearing microparticle arm was 17.3 months (red).